2024-11-20 02:24:47
Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study
Corporate/ 2023-07-23
Completion of Patients' Recruitment...

SUZHOU,China,Feb.22,2021-- Kintor Pharmaceutical Limited (HKEX:9939) is pleased to announce thatthe clinical trial of Proxalutamide for the ...

Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b PTSD Trial
Corporate/ 2023-07-23
Positive BNC210 7-Day Dosing Pharmacokin...

BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase 2b PTSD trial

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release